Tislelizumab (anti-PD-1 monoclonal antibody) should be individualized for patients in special populations, with key considerations for pregnant women,···【Read More】
Update: 2026-02-27Source: Haiou HealthViews: 77
Patients treated with tislelizumab injection should focus on adverse reaction monitoring, infection prevention and management of special populations, ···【Read More】
Update: 2026-02-27Source: Haiou HealthViews: 74
As an immunotherapeutic agent (PD-1 inhibitor), the main side effects of tislelizumab stem from an overactivated immune system attacking normal body t···【Read More】
Update: 2026-02-27Source: Haiou HealthViews: 79
The recommended standard dosage of Tislelizumab for adults is 200 mg administered via intravenous infusion, once every 3 weeks.The specific dosage sha···【Read More】
Update: 2026-02-27Source: Haiou HealthViews: 78
Tislelizumab is an antineoplastic biological agent, with the active ingredient being a humanized recombinant anti-PD-1 monoclonal antibody. It mainly ···【Read More】
Update: 2026-02-27Source: Haiou HealthViews: 79
Fruquintinib is a targeted therapy used for metastatic colorectal cancer, and its administration requires strict attention to contraindications. Altho···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 81
The use of fruquintinib must be strictly guided by a doctor, with key focus on monitoring adverse reactions, drug interactions and lifestyle adjustmen···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 80
Fruquintinib Capsules is an antineoplastic drug mainly used for the treatment of metastatic colorectal cancer. Its common side effects include hyperte···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 74
The administration of fruquintinib must follow strict medical guidance. It is commonly indicated for the treatment of metastatic colorectal cancer. Th···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 80
Fruquintinib capsules are a dedicated tumor angiogenesis inhibitor. They exert their effects mainly by blocking the VEGFR kinase family (three key tar···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 81
Rezvilutamide Tablets are a novel androgen receptor inhibitor, mainly indicated for the treatment of prostate cancer. Administration in special popula···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 79
Rezvilutamide Tablets is a prescription medication for the treatment of certain types of prostate cancer and must be used strictly under medical super···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 76
Rezvilutamide Tablets are an anti-androgen medication used for the treatment of prostate cancer. Their side effects mainly involve the endocrine, dige···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 78
The dosage of Rezvilutamide Tablets must be administered in strict accordance with medical advice. The usual recommended dose is 300 mg (3 tablets) on···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 79
Rezvilutamide Tablets belong to the second-generation androgen receptor (AR) inhibitors and represent China's first independently developed novel ···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 75
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



